| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 105.314 | 55.128 | 18.140 | 7.087 | 7.750 | 7.186 | 52.923 | 148.423 |
| Total Income - EUR | - | - | 106.269 | 56.250 | 21.227 | 9.391 | 9.595 | 10.124 | 57.067 | 148.971 |
| Total Expenses - EUR | - | - | 1.477 | 7.256 | 3.954 | 8.460 | 8.977 | 15.912 | 15.820 | 15.828 |
| Gross Profit/Loss - EUR | - | - | 104.792 | 48.994 | 17.273 | 931 | 619 | -5.788 | 41.247 | 133.143 |
| Net Profit/Loss - EUR | - | - | 102.183 | 48.442 | 16.657 | 662 | 344 | -5.859 | 40.728 | 128.779 |
| Employees | - | - | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nicolosu Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 57 | 16 | 28.198 | 22.037 | 17.266 | 11.348 | 6.371 | 960 |
| Current Assets | - | - | 104.791 | 150.015 | 129.837 | 127.831 | 123.763 | 3.714 | 54.765 | 252.179 |
| Inventories | - | - | 0 | 0 | 0 | 325 | 318 | 319 | 0 | 0 |
| Receivables | - | - | 8.923 | 1 | 3.510 | 3.236 | 1.613 | 828 | 34.863 | 119.185 |
| Cash | - | - | 95.867 | 150.014 | 126.327 | 124.271 | 121.832 | 2.567 | 19.902 | 132.994 |
| Shareholders Funds | - | - | 102.592 | 149.152 | 157.863 | 149.744 | 140.905 | -5.811 | 34.935 | 128.827 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.255 | 879 | 172 | 124 | 124 | 20.873 | 26.202 | 124.311 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicolosu Med Srl